• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎(COVID-19):SARS-CoV-2 的形态与机制、全球疫情爆发、药物治疗、疫苗及病毒的未来。

COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.

机构信息

Department of Botany, Dinabandhu Andrews College, Garia, Kolkata, 700084 West Bengal, India.

Department of Botany, Vivekananda College, Thakurpukur, Kolkata, 700063 West Bengal, India.

出版信息

Front Biosci (Elite Ed). 2021 Dec 20;13(2):272-290. doi: 10.52586/E884.

DOI:10.52586/E884
PMID:34937314
Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a lethal virus that was detected back on 31st December 2019 in Wuhan, Hubei province in China, and since then this virus has been spreading across the globe causing a global outbreak and has left the world fighting against the virus. The disease caused by the SARS-CoV-2 was named COVID-19 and this was declared a pandemic disease by the World Health Organization on 11th March 2020. Several nations are trying to develop a vaccine that can save millions of lives. This review outlines the morphological features of the virus describing the outer and inner structures of the virus along with the entry mechanism of the virus into the host body and the infection process. Detailed reports of global outbreak along with preventive measures have also been included, with special emphasis on China, the United States of America, India, Italy, and South Korea. Broad-spectrum antiviral drugs being used at various health care centres around the world, namely Remdesivir, Camostat & Nafamostat, Famotidine, Chloroquine & Hydroxychloroquine, Lopinavir/ritonavir, Ivermectin, and Tocilizumab & Sarilumab have also been included. World Health Organization guidelines on preventive measures and use of soaps, alcohol-based hand-rubs and wearing face masks have also been described. The vaccines that are in one of the phases of human trials, namely Oxford University's vaccine, the United States-based Moderna's vaccine, India's Covaxin and the Russian vaccine, have also been incorporated in the review article.

摘要

严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)是一种致命病毒,于 2019 年 12 月 31 日在中国湖北省武汉市被发现,自此,该病毒在全球范围内传播,引发全球疫情,使世界各国都在与该病毒作斗争。由 SARS-CoV-2 引起的疾病被命名为 COVID-19,世界卫生组织于 2020 年 3 月 11 日宣布该疾病为大流行疾病。许多国家正在努力开发可以挽救数百万人生命的疫苗。这篇综述概述了病毒的形态特征,描述了病毒的外部和内部结构以及病毒进入宿主身体的机制和感染过程。还包括了全球疫情的详细报告以及预防措施,特别强调了中国、美国、印度、意大利和韩国。还包括了世界各地的各个医疗机构正在使用的广谱抗病毒药物,即瑞德西韦、卡莫司他和那法莫司他、法莫替丁、氯喹和羟氯喹、洛匹那韦/利托那韦、伊维菌素和托珠单抗/沙利鲁单抗。还描述了世界卫生组织关于预防措施以及肥皂、酒精类洗手液和戴口罩使用的指南。还将处于人体试验阶段的疫苗,即牛津大学的疫苗、美国的 Moderna 疫苗、印度的 Covaxin 和俄罗斯的疫苗纳入综述文章。

相似文献

1
COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.新型冠状病毒肺炎(COVID-19):SARS-CoV-2 的形态与机制、全球疫情爆发、药物治疗、疫苗及病毒的未来。
Front Biosci (Elite Ed). 2021 Dec 20;13(2):272-290. doi: 10.52586/E884.
2
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.关于在疫情爆发情况下治疗新型冠状病毒(SARS-CoV-2)的新兴治疗和预防策略的循证系统评价。
J Basic Clin Physiol Pharmacol. 2020 Sep 14;31(6):jbcpp-2020-0113. doi: 10.1515/jbcpp-2020-0113.
3
COVID-19 Infection: Targeting Possibilities for Treatment.COVID-19 感染:治疗目标的可能性。
Crit Rev Ther Drug Carrier Syst. 2021;38(3):75-115. doi: 10.1615/CritRevTherDrugCarrierSyst.2021035392.
4
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.SARS-CoV-2/COVID-19 大流行管理的潜在治疗靶点和疫苗开发:近期进展综述。
Front Immunol. 2021 Jun 30;12:658519. doi: 10.3389/fimmu.2021.658519. eCollection 2021.
5
Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines.用于对抗 SARS-CoV-2 感染的有效药物和当前疫苗的状况。
Biomed Pharmacother. 2021 May;137:111330. doi: 10.1016/j.biopha.2021.111330. Epub 2021 Jan 28.
6
Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV.针对 SARS-CoV 的杰出抗病毒候选药物的合成尝试。
Mini Rev Med Chem. 2022;22(2):232-247. doi: 10.2174/1389557521666210712205655.
7
The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic.新冠疫情背景下的药物重定位和疫苗研发现状。
Int J Mol Sci. 2020 Dec 21;21(24):9775. doi: 10.3390/ijms21249775.
8
Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.不同治疗干预措施对新型冠状病毒肺炎防治的安全性与有效性
J Nepal Health Res Counc. 2020 Sep 7;18(2):151-158. doi: 10.33314/jnhrc.v18i2.2806.
9
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.COVID-19:具有悠久历史、流行病学和迄今进展的全球性挑战。
Molecules. 2020 Dec 23;26(1):39. doi: 10.3390/molecules26010039.
10
Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.新型冠状病毒:从起源到治疗策略现状的综述。
Crit Rev Eukaryot Gene Expr. 2021;31(3):21-34. doi: 10.1615/CritRevEukaryotGeneExpr.2021038075.

引用本文的文献

1
The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19.益生菌作为可摄入佐剂和免疫调节剂在抗病毒免疫以及严重急性呼吸综合征冠状病毒2感染和2019冠状病毒病管理中的潜力
Pathogens. 2023 Jul 11;12(7):928. doi: 10.3390/pathogens12070928.
2
A Nomogram for Predicting Delayed Viral Shedding in Non-Severe SARS-CoV-2 Omicron Infection.预测非重症严重急性呼吸综合征冠状病毒2型奥密克戎感染中病毒延迟脱落的列线图
Infect Drug Resist. 2023 Apr 27;16:2487-2500. doi: 10.2147/IDR.S407620. eCollection 2023.